ArticleDie Ophthalmologie2026
[Oncocytoma of the eyelid: case series with histopathological correlation].
Article in Die Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eyelid oncocytomas are rare benign epithelial tumors that cannot be reliably distinguished clinically from other benign or malignant eyelid margin lesions. This case series describes three patients aged 64 to 77 years with slowly progressive, well-circumscribed, reddish-violaceous lesions of the lower eyelid, two of which were located peripunctally. Histopathology revealed sharply demarcated epithelial tumors composed of polygonal oncocytes with finely granular eosinophilic cytoplasm and predominantly adenoid or tubular architecture. Immunohistochemistry showed tumor cell positivity for cytokeratin 7 (CK7), a low Ki-67 proliferation index, and focal positivity of myoepithelial cell components for α-smooth muscle actin (SMA). After complete excision, no recurrence was observed during 10 to 18 months of follow-up. Oncocytoma should be considered in the differential diagnosis of chronic progressive, reddish-livid eyelid margin lesions, particularly in older patients. Histopathologic confirmation is essential, as complete excision is diagnostic and usually curative.
Indexed as
Identifiers
42265344What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.